These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 25556152)

  • 61. [Practical guidelines for diagnosis and treatment of acromegaly. Grupo de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición].
    Cordido F; García Arnés JA; Marazuela Aspiroz M; Torres Vela E;
    Endocrinol Nutr; 2013 Oct; 60(8):457.e1-457.e15. PubMed ID: 23660006
    [No Abstract]   [Full Text] [Related]  

  • 62. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue.
    Comi RJ; Gesundheit N; Murray L; Gorden P; Weintraub BD
    N Engl J Med; 1987 Jul; 317(1):12-7. PubMed ID: 2884564
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pituitary-directed medical therapy in Cushing's disease.
    Petersenn S; Fleseriu M
    Pituitary; 2015 Apr; 18(2):238-44. PubMed ID: 25627118
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Endoscopic transsphenoidal treatment of hormonally active pituitary adenomas.
    Rudnik A; Kos-Kudła B; Larysz D; Zawadzki T; Bazowski P
    Neuro Endocrinol Lett; 2007 Aug; 28(4):438-44. PubMed ID: 17693972
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-term follow-up results of multimodal treatment with initial surgical approach for acromegaly in a single center.
    Van Rompaey K; Unuane D; Moens M; Duerinck J; Poppe K; Velkeniers B; D'Haens J
    Acta Neurol Belg; 2013 Mar; 113(1):49-54. PubMed ID: 22975835
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management of hormone-secreting pituitary adenomas.
    Mehta GU; Lonser RR
    Neuro Oncol; 2017 Jun; 19(6):762-773. PubMed ID: 27543627
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Medical treatment of prolactin and growth hormone-secreting pituitary tumors].
    Jadresic A
    Rev Med Chil; 1997 Nov; 125(11):1383-8. PubMed ID: 9609063
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evidence for dopamine agonists in the treatment of acromegaly.
    Jaquet P
    J Endocrinol; 1997 Oct; 155 Suppl 1():S59-60. PubMed ID: 9389998
    [No Abstract]   [Full Text] [Related]  

  • 69. Double pituitary adenomas: a series of three patients.
    McKelvie PA; McNeill P
    Pathology; 2002 Feb; 34(1):57-60. PubMed ID: 11902447
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of medical therapy on pituitary tumors.
    Kovacs K; Horvath E
    Ultrastruct Pathol; 2005; 29(3-4):163-7. PubMed ID: 16036872
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas.
    Biller BM; Colao A; Petersenn S; Bonert VS; Boscaro M
    BMC Endocr Disord; 2010 May; 10():10. PubMed ID: 20478050
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Radiotherapy of pituitary adenomas: state of the art.
    Gilliot O; Khalil T; Irthum B; Zasadny X; Verrelle P; Tauveron I; Pontvert D
    Ann Endocrinol (Paris); 2007 Oct; 68(5):337-48. PubMed ID: 17512895
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Advances in the medical treatment of Cushing's syndrome.
    Feelders RA; Newell-Price J; Pivonello R; Nieman LK; Hofland LJ; Lacroix A
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):300-312. PubMed ID: 30033041
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinically active pituitary tumors].
    Unger N; Theodoropoulou M; Schilbach K
    Inn Med (Heidelb); 2024 Jul; 65(7):672-680. PubMed ID: 38869654
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Difficulties of treating acromegaly in the light of 12 years of experience].
    Gulyás E; Molnár K; Kajtár B; Radics B; Dóczi T; Mezősi E; Nemes O
    Orv Hetil; 2024 Oct; 165(40):1587-1593. PubMed ID: 39369379
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antiproliferative effects of somatostatin analogs in pituitary adenomas.
    Zatelli MC; Piccin D; Ambrosio MR; Bondanelli M; degli Uberti EC
    Pituitary; 2006; 9(1):27-34. PubMed ID: 16703406
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies.
    Wexler TL; Page-Wilson G
    Br J Clin Pharmacol; 2023 Apr; 89(4):1304-1317. PubMed ID: 36630197
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Medical treatment of secretory hypophyseal adenomas].
    Thomopoulos P
    Neurochirurgie; 1998 Dec; 44(5):309-11. PubMed ID: 9915009
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas.
    Hinojosa-Amaya JM; Johnson N; González-Torres C; Varlamov EV; Yedinak CG; McCartney S; Fleseriu M
    Front Endocrinol (Lausanne); 2020; 11():579606. PubMed ID: 33193096
    [No Abstract]   [Full Text] [Related]  

  • 80. Comment on "Non-surgical treatment of hormone-secreting pituitary tumors".
    Dobson M; Del Porto L; Maartens NF
    J Clin Neurosci; 2010 Sep; 17(9):1220-1. PubMed ID: 20570519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.